Cargando…

microRNA-mRNA Profile of Skeletal Muscle Differentiation and Relevance to Congenital Myotonic Dystrophy

microRNAs (miRNAs) regulate messenger RNA (mRNA) abundance and translation during key developmental processes including muscle differentiation. Assessment of miRNA targets can provide insight into muscle biology and gene expression profiles altered by disease. mRNA and miRNA libraries were generated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morton, Sarah U., Sefton, Christopher R., Zhang, Huanqing, Dai, Manhong, Turner, David L., Uhler, Michael D., Agrawal, Pankaj B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962092/ https://www.ncbi.nlm.nih.gov/pubmed/33799993 http://dx.doi.org/10.3390/ijms22052692

Ejemplares similares

MicroRNA-Based Therapeutic Perspectives in Myotonic Dystrophy
por: López Castel, Arturo, et al.
Publicado: (2019)

Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients
por: Gambardella, Stefano, et al.
Publicado: (2010)

Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy
por: Thomas, James D., et al.
Publicado: (2017)

Congenital myotonic dystrophy—an RNA-mediated disease across a developmental continuum
por: Jagannathan, Sujatha, et al.
Publicado: (2017)

Antenatal Indomethacin Treatment for Congenital Myotonic Dystrophy
por: Yamaguchi, Kyohei, et al.
Publicado: (2019)

Fuchs' Endothelial Corneal Dystrophy and RNA Foci in Patients With Myotonic Dystrophy
por: Mootha, V. Vinod, et al.
Publicado: (2017)

Targeting nuclear RNA for in vivo correction of myotonic dystrophy
por: Wheeler, Thurman M., et al.
Publicado: (2012)

Quantitative Methods to Monitor RNA Biomarkers in Myotonic Dystrophy
por: Wojciechowska, Marzena, et al.
Publicado: (2018)

Global Increase in Circular RNA Levels in Myotonic Dystrophy
por: Czubak, Karol, et al.
Publicado: (2019)

Clinical characteristics of pregnancies complicated by congenital myotonic dystrophy
por: Yee, Cheonga, et al.
Publicado: (2017)

Myotonic dystrophy
por: Patterson, VH
Publicado: (1990)

RNA Transcription and Maturation in Skeletal Muscle Cells are Similarly Impaired in Myotonic Dystrophy and Sarcopenia: The Ultrastructural Evidence
por: Malatesta, Manuela, et al.
Publicado: (2014)

Case Report of Congenital Kyphoscoliosis with Myotonic Dystrophy Type 1: Perioperative and Anesthetic Considerations
por: Agrawal, Arpit, et al.
Publicado: (2021)

TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2
por: Bosè, Francesca, et al.
Publicado: (2019)

Induction and Reversal of Myotonic Dystrophy Type 1 Pre-mRNA Splicing Defects by Small Molecules
por: Childs-Disney, Jessica L., et al.
Publicado: (2013)

Defining early steps in mRNA transport: mutant mRNA in myotonic dystrophy type I is blocked at entry into SC-35 domains
por: Smith, Kelly P., et al.
Publicado: (2007)

Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy
por: André, Laurène M., et al.
Publicado: (2018)

Deregulated MicroRNAs in Myotonic Dystrophy Type 2
por: Greco, Simona, et al.
Publicado: (2012)

Oral administration of erythromycin decreases RNA toxicity in myotonic dystrophy
por: Nakamori, Masayuki, et al.
Publicado: (2015)

Mitigating RNA Toxicity in Myotonic Dystrophy using Small Molecules
por: Reddy, Kaalak, et al.
Publicado: (2019)

Overexpression of CUGBP1 in Skeletal Muscle from Adult Classic Myotonic Dystrophy Type 1 but Not from Myotonic Dystrophy Type 2
por: Cardani, Rosanna, et al.
Publicado: (2013)

Cancer and Myotonic Dystrophy
por: D’Ambrosio, Eleonora S., et al.
Publicado: (2023)

Combined microRNA and mRNA detection in mammalian retinas by in situ hybridization chain reaction
por: Zhuang, Pei, et al.
Publicado: (2020)

Computational Investigation of RNA CUG Repeats Responsible for Myotonic Dystrophy 1
por: Yildirim, Ilyas, et al.
Publicado: (2015)

Short Tandem Repeat Expansions and RNA-Mediated Pathogenesis in Myotonic Dystrophy
por: Sznajder, Łukasz J., et al.
Publicado: (2019)

Fetal Macrocephaly: A Novel Sonographic Finding in Congenital Myotonic Dystrophy
por: Shinar, Shiri, et al.
Publicado: (2020)

Impact of prematurity and the CTG repeat length on outcomes in congenital myotonic dystrophy
por: Saito, Yu, et al.
Publicado: (2020)

Congenital Myotonic Dystrophy and Brugada Syndrome: A Report of Two Cases
por: Gupta, Kunal, et al.
Publicado: (2020)

ZNF9 Activation of IRES-Mediated Translation of the Human ODC mRNA Is Decreased in Myotonic Dystrophy Type 2
por: Sammons, Morgan A., et al.
Publicado: (2010)

Disease burden of myotonic dystrophy type 1
por: Landfeldt, Erik, et al.
Publicado: (2019)

Desflurane anaesthesia in myotonic dystrophy
por: Gandhi, Ranju, et al.
Publicado: (2011)

Myotonic Dystrophy: An Anaesthetic Dilemma
por: Gupta, N, et al.
Publicado: (2009)

Cardiac involvement in myotonic dystrophy
por: Khalighi, Koroush, et al.
Publicado: (2015)

Steakhouse Syndrome in Myotonic Dystrophy
por: Ogasawara, Nobuhiko, et al.
Publicado: (2017)

Cutaneous findings in myotonic dystrophy
por: Kong, Ha Eun, et al.
Publicado: (2022)

Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1
por: Perfetti, A., et al.
Publicado: (2016)

Targeted splice sequencing reveals RNA toxicity and therapeutic response in myotonic dystrophy
por: Tanner, Matthew K, et al.
Publicado: (2021)

Quercetin selectively reduces expanded repeat RNA levels in models of myotonic dystrophy
por: Mishra, Subodh K., et al.
Publicado: (2023)

Dynamics and variability of transcriptomic dysregulation in congenital myotonic dystrophy during pediatric development
por: Hale, Melissa A, et al.
Publicado: (2022)

AON-induced splice-switching and DMPK pre-mRNA degradation as potential therapeutic approaches for Myotonic Dystrophy type 1
por: Stepniak-Konieczna, Ewa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l9vob5pgv4gtmulgste9h68p66